Clinical surrogate markers of survival in advanced non-small cell lung cancer (NSCLC) patients treated with second–third line erlotinib

✍ Scribed by Cedrés, Susana; Prat, Aleix; Martínez, Pablo; Pallisa, Esther; Sala, Gemma; Andreu, Jordi; del Campo, J.M.; Quispe, Isela; Baselga, José; Felip, Enriqueta

• Book ID: 119320109
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 341 KB
• Volume: 66
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/j.lungcan.2009.01.014